123 related articles for article (PubMed ID: 8304132)
21. Fluorodeoxyglucose brain metabolism studied by NMR and PET.
Bolo NR; Brennan KM; Jones RM; Budinger TF
Ann N Y Acad Sci; 1987; 508():451-9. PubMed ID: 3501936
[No Abstract] [Full Text] [Related]
22. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
[TBL] [Abstract][Full Text] [Related]
23. (S)-(-)-[11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain.
Lundqvist H; Nordberg A; Hartvig P; Långström B
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):238-46. PubMed ID: 9772029
[TBL] [Abstract][Full Text] [Related]
24. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
[TBL] [Abstract][Full Text] [Related]
25. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
Alavi A; Smith R; Duncan D
J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
[No Abstract] [Full Text] [Related]
26. [Positron emission tomography of the brain. A diagnostic technic on the threshold of clinical use].
Heiss WD
Dtsch Med Wochenschr; 1983 Jun; 108(23):887-90. PubMed ID: 6602042
[No Abstract] [Full Text] [Related]
27. [Functional brain study by radionuclide neuroimaging].
Uemura K
No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
[No Abstract] [Full Text] [Related]
28. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
29. In vitro positron emission tomography (PET): use of positron emission tracers in functional imaging in living brain slices.
Matsumura K; Bergström M; Onoe H; Takechi H; Westerberg G; Antoni G; Bjurling P; Jacobson GB; Långström B; Watanabe Y
Neurosci Res; 1995 May; 22(2):219-29. PubMed ID: 7566703
[TBL] [Abstract][Full Text] [Related]
30. Blood-brain barrier transport measurements using PET-scanning and intravenous double indicator technique.
Knudsen GM
Adv Exp Med Biol; 1993; 333():251-6. PubMed ID: 8362665
[No Abstract] [Full Text] [Related]
31. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
Schmidt KC; Lucignani G; Sokoloff L
J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
[No Abstract] [Full Text] [Related]
32. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
[TBL] [Abstract][Full Text] [Related]
33. Effect of stimulation or inhibition of muscarinic or nicotinic receptors on the content of biogenic amines in various parts of rat brain.
Bień E; Herman ZS
Acta Physiol Pol; 1983; 34(2):227-32. PubMed ID: 6141700
[TBL] [Abstract][Full Text] [Related]
34. Radiolabeled ligands for imaging the muscarinic-cholinergic receptors of the heart and brain.
Knapp FF; McPherson DW; Luo H; Zeeburg B
Anticancer Res; 1997; 17(3B):1559-72. PubMed ID: 9179195
[TBL] [Abstract][Full Text] [Related]
35. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
Schelbert HR
Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
[No Abstract] [Full Text] [Related]
36. Repeated peripheral administration of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin alters the binding activities of 5-HT1A and 5-HT2 receptors in rat brain.
Muguruma K; Imamura K; Watanabe Y
Biochem Biophys Res Commun; 1996 Oct; 227(3):794-9. PubMed ID: 8886012
[TBL] [Abstract][Full Text] [Related]
37. [Tomographic measurement of human cerebral glucose metabolism].
Iwasaki Y; Konishi J; Makada Y; Yonekura Y
Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
[No Abstract] [Full Text] [Related]
38. A potential cholinergic mechanism of procaine's limbic activation.
Benson BE; Carson RE; Kiesewetter DO; Herscovitch P; Eckelman WC; Post RM; Ketter TA
Neuropsychopharmacology; 2004 Jul; 29(7):1239-50. PubMed ID: 14997171
[TBL] [Abstract][Full Text] [Related]
39. Simplified calculation of MRglc using PET.
Phillips RL; London ED
J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
[No Abstract] [Full Text] [Related]
40. Basic principles in imaging of regional cerebral metabolic rates.
Sokoloff L
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():21-49. PubMed ID: 2992057
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
